中文名称: AK-7
英文名称: AK-7
CAS No: 420831-40-9
分子式: C19H21BrN2O3S
分子量: 437.35
A11413 AK-7 ≥98% (psaitong)
包装规格:
100mg in glass bottle
溶解性:
溶于DMSO(≥50mg/mL)
产品描述:

基本信息

产品编号:A11413

产品名称:AK-7

CAS:

420831-40-9

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C19H21BrN2O3S

溶于液体

-80℃

两年

分子量

437.35

-20℃

一个月

化学名: 

3-(azepan-1-ylsulfonyl)-N-(3-bromophenyl)benzamide

 

Solubility (25°C)

 

体外

DMSO

87mg/mL (198.92mM)

Ethanol

3mg/mL (6.85mM)

Water

Insoluble

体内

现配现用

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.2865mL

11.4325mL

22.8650mL

5mM

0.4573mL

2.2865mL

4.5730mL

10mM

0.2286mL

1.1432mL

2.2865mL

50mM

0.0457mL

0.2286mL

0.4573mL

 

 

生物活性

产品描述

一种可透过细胞及血脑屏障的 SIRT2 抑制剂,IC50 值为 15.5μM。

靶点/IC50

SIRT2 
()

15.5μM

 

体外研究

AK-7 (10μM) reduces cholesterol levels in naive N2a neuroblastoma cells and hippocampal slice cultures from wild-type mice. AK-7 (1μM) shows neuroprotective effect of AK-7 in striatal Huntington’s disease (HD) neurons. AK-7 (12.5μM) decreases ratio of DA neurons in primary midbrain cultures.

 

体内研究

AK-7 (15 mg/kg/dose, i.p.) is brain-permeable in wild-type and HD mice. AK-7 (10, 20 mg/kg, i.p.) improves the behavior and neuropathological phenotype and extends survival of R6/2 HD mice. AK-7 (20mg/kg) ameliorates HD neuropathology in R6/2 mice. AK-7 also reduces the polyglutamine aggregation in R6/2 brain. In addition, AK-7 treated 140CAG mice show motor performance changes that parallel untreated wild-type mice, with the 20mg/kg dose being most effective and significantly different from untreated 140CAG mice.

 

 

 

推荐实验方法(仅供参考)

细胞实验:

Cell Assay

Neuronal nuclear antigen (NeuN)-positive neurons and some astroglia are derived from mechanically dissociated ganglionic eminences of E16 rat embryos. The HD model is based on the expression of mutant huntingtin. Treatments of cultures with AK-7 are at 10μM for 24h unless stated otherwise. DMSO is included at the same concentrations as a control. Lower dose, chronic treatments with AK-7 are introduced to neurons at DIV4 and continued weekly coinciding with normal medium change.

 

动物实验:

 

Animal Administration

AK-7, solubilized at 1.5mg/mL in 25% Cremophor EL (BASF)/ 10% DMSO in water, is administered by intraperitoneal injection to 11 week old mice at 15 mg/kg/dose, and compound levels in serum and brain are measured following sacrifice.Blood is collected and centrifuged at 7,000 rpm for 7 min, and then serum is aspirated and immediately frozen in liquid nitrogen. Brains are immediately frozen in liquid nitrogen and stored at −80°C. Brains are weighed and then homogenized in four volumes of 10% Cremophor RH40 in water using a Polytron homogenizer, and 2% v/v phosphoric acid is added to the homogenate, vortexed, and centrifuged at 10,000 g at 25°C for 1 h. The supernatant is aspirated, and solid phase extraction is performed immediately. Serum samples are vortexed into 2% v/v phosphoric acid and centrifuged at 2500 rpm for 10min

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):